Course ID: | PHAR 6340E. 3 hours. |
Course Title: | European Pharmaceutical and Biologics Regulatory Sciences |
Course Description: | An in-depth examination of the European Biomedical Regulatory
landscape for obtaining marketing approval for drugs and
biologics in the European Union, including early medical product
development, clinical trial phases, marketing, and
pharmacovigilance. |
Oasis Title: | EU Biomedical Regulatory Scien |
Nontraditional Format: | This course will be taught 95% or more online. |
Prerequisite: | PHAR 6010 or PHAR 6010E or permission of department |
Grading System: | A-F (Traditional) |
|
Course Objectives: | Upon completion of this course, students will be able to
demonstrate:
1. An understanding of the European Regulatory structure and
agencies involved with filing a new medicinal product
application.
2. An understanding of the significance of the organizational
structure of European Commission and Notified Bodies.
3. An understanding of the different approaches in regulating
different types of medicinal products, including Council
Regulations and Directives.
4. An understanding of the differences between pre-market
approval decision making and post-market compliance decision
making.
5. An understanding of international pharmacovigilance.
6. To develop a basic understanding of the Quality Systems and
Inspection Processes for Pharmaceutical Companies.
7. To develop the ability to think critically about how
regulatory agencies help protect the health and safety of
people around the world.
8. What it takes to grant a Medicinal Product and Marketing
Authorisation in Europe.
9. To understand the legal obligations of the Marketing
Authorisation holder; what the different options are and how to
maintain a dossier life cycle. |
Topical Outline: | Topic
Mod 0 – Introduction and history of EM(E)A and glossary of 200
definitions
Mod 1 – Regulatory strategy and pre-submission – Intro and
definitions – Part A
Mod 2 – Regulatory strategy and pre-submission – Intro and
definitions – Part B
Mod 3 – Regulatory strategy and pre-submission – Possible
options and support
Mod 4 – Regulatory strategy and pre-submission – Patent, data
exclusivity, and data protection
Mod 5 – Regulatory strategy and pre-submission – Standard drug
development process
Mod 6 – Regulatory strategy and pre-submission – The art of
writing a regulatory submission dossier
Mod 7 – Dossier preparation and submission – Part A
Mod 8 – Dossier preparation and submission – Part B
Mod 9 – Approval process – Centralized procedure
Mod 10 – Approval process – MRP procedure
Mod 11 – Approval process – DCP and national procedure
Mod 12 – Approval process – Implementation and license
Mod 13 – Post approval commitments and responsibilities
Mod 14 – Life Cycle management – Part A
Mod 15 – Life Cycle management – Part B |
Honor Code Reference: | All academic work must meet the standards contained in A
Culture of Honesty. Each student is responsible to inform
themselves about those standards before performing any
academic work. A Culture of Honesty is the University of
Georgia’s policy and procedures for handling cases of
suspected dishonesty and can be found online at
www.uga.edu/honesty. The UGA Student Honor Code states “I
will be academically honest in all of my academic work and
will not tolerate academic dishonesty of others.” |